<X-CLARIS-WINDOW TOP=44 BOTTOM=757 LEFT=4 RIGHT=534>

COST Action B22 on "Drug development for parasitic diseases"

2003-2007

On February, 28th, 2003, the new Cost-B22 Action on "Drug development for parasitic diseases" has officially started by the signing of the memorandum of understanding by 16 countries, Austria, Belgium, Bulgaria, Czech Republic, Denmark, France, Germany, Greece, Ireland, Israel, Italy, Slovakia, Spain, Sweden, Switzerland, The Netherlands and the United Kingdom.

The present signatories (and their number of participants):

Members 

  • Austria (1)
  • Belgium (2)
  • Bulgaria (1)
  • Canada (1)
  • Czech Republic (1)
  • Denmark (1)
  • France (2)
  • Germany (2)
  • Greece (2)
  • Ireland (1)
  • Israel (2)
  • Italy (2)
  • Lithuania (2)
  • Luxemburg (1)
  • Portugal (2)
  • Slovakia (2)
  • Spain (2)
  • Sweden (2)
  • Switzerland (2)
  • The Netherlands (2)
  • United Kingdom (2)

Observers 

  • Int. Org. for Chemistry in Development (IOCD)
  • ARC-network on parasitology (Australia)
  • Seattle Inst. Biomed. Res. (USA)
  • University of Cape Town, SA

 Back to Index